The Biden administration will defend its COVID-19 vaccine mandates for businesses as legal challenges mount, Surgeon General Dr. Vivek Murthy said. The deadline for companies with 100 or more employees to vaccinate all workers is January 4. (The New York Times)

Regeneron’s monoclonal antibodies reduce the risk of COVID-19 infection by 82% for eight months. Immunocompromised people could receive the antibody cocktail every five to six months, the company said. (CNBC Weekly)

The European Union will provide recommendations for the use of Merck’s COVID-19 antiviral pill in the “shortest possible” time period. The therapy cuts the risk of hospitalization and death in half. (Reuters)

Centers for Disease Control and Prevention Director Rochelle Walensky had a plan to revive the agency following its decline in recent years. But experts said the agency has continued to falter during the Biden administration. (STAT)

GlaxoSmithKline has compiled data from five trials examining its oral anemia drug, daprodustat, which will soon be shared with the Food and Drug Administration. Dapro treats chronic kidney disease. (Endpoints News)